Ureaplasma is sexually transmitted, but most medical authorities do not classify it as a sexually transmitted infection. The distinction matters: Ureaplasma bacteria live harmlessly in the genital tracts of a large percentage of healthy adults, and carrying them does not mean you have an infection that needs treatment. Around 14% of people with no symptoms at all test positive for Ureaplasma urealyticum, and rates for the more common species, Ureaplasma parvum, are even higher.
This gray area causes real confusion, especially when private testing companies offer Ureaplasma panels and return a positive result. Here’s what the science actually says about transmission, risk, and when Ureaplasma crosses the line from harmless passenger to genuine problem.
Why It’s Not Considered a Standard STI
Ureaplasma spreads through sexual contact and from mother to baby during birth. By that definition, it sounds like a textbook STI. But the key distinction is that Ureaplasma is a normal resident of the genital tract for many people. It can live there for years without causing symptoms or damage, which sets it apart from infections like chlamydia or gonorrhea, where a positive test reliably indicates an infection that needs treatment.
The British Association for Sexual Health and HIV (BASHH) puts it plainly: although Ureaplasma can be passed on through sex, it is “not an STI because it is a normal organism and not an infection.” The CDC’s STI treatment guidelines take a similar position, noting that data linking Ureaplasma to conditions like urethritis and cervicitis are inconsistent and that routine testing is not recommended. NHS sexual health clinics in the UK do not test for it at all.
When Ureaplasma Does Cause Problems
Just because Ureaplasma isn’t classified as an STI doesn’t mean it never causes harm. In certain circumstances, particularly when bacterial loads are high, it can trigger real symptoms. The CDC notes that the majority of men carrying Ureaplasma have no overt disease “unless a high organism load is present.” When it does cause symptoms, they overlap with more common infections:
- In men: urethritis (burning with urination, urethral discharge), which can mimic chlamydia or gonorrhea
- In women: vaginal discharge, itching, and pelvic discomfort, though the evidence linking Ureaplasma specifically to cervicitis is weak
The challenge is that a positive Ureaplasma test in someone with symptoms doesn’t prove Ureaplasma is the cause. Other infections could be responsible, and treating Ureaplasma without ruling those out can lead to unnecessary antibiotics and missed diagnoses.
Two Species, Different Risk Profiles
There are two species you’ll see on test results: Ureaplasma parvum and Ureaplasma urealyticum. They’re not interchangeable in terms of clinical significance. U. parvum is the more common of the two and shows up frequently in healthy women with no symptoms. U. urealyticum is less common but has been more strongly linked to complications like infertility and adverse pregnancy outcomes.
Research from Brazilian public health clinics found that U. urealyticum was associated with having multiple sexual partners and triggered higher levels of inflammatory markers in cervical tissue. U. parvum also provoked some inflammatory response but was more broadly distributed across sexually active women regardless of symptoms. In practical terms, a positive result for U. parvum alone is less concerning than one for U. urealyticum, though neither result in an asymptomatic person typically warrants treatment.
Pregnancy Is the Major Exception
The strongest evidence for Ureaplasma causing genuine harm comes from pregnancy research. Ureaplasma species are the most common organisms found in amniotic fluid from women who go into preterm labor with intact membranes, experience early water breaking, or have a shortened cervix with bacterial invasion of the amniotic cavity.
When Ureaplasma reaches the upper genital tract and is the only microbe present, it is significantly associated with premature delivery, complications in newborns, and perinatal death. Animal studies in rhesus macaques have confirmed a direct causal link between Ureaplasma intrauterine infection and preterm labor, not just a correlation. The bacteria trigger an inflammatory cascade that leads to uterine contractions, cervical changes, and membrane rupture.
In one study, 78% of placentas from infants colonized with Ureaplasma showed signs of chorioamnionitis (infection of the placental membranes), compared to 36% of culture-negative infants. Ureaplasma has also been linked to early pregnancy loss, stillbirth, and infertility. This is the context in which doctors are most likely to take a positive Ureaplasma result seriously and recommend treatment.
Testing: Why More Isn’t Always Better
Private sexual health companies increasingly offer Ureaplasma testing, often as part of premium STI panels. This sounds thorough but creates a real problem: a positive result in someone without symptoms can cause significant anxiety and lead to antibiotic courses that aren’t necessary.
BASHH explicitly warns that private Ureaplasma testing is one of “the tests you don’t need from a sexual health service.” Their guidance states that your sexual partners do not need to be tested or treated based on a Ureaplasma result alone. A standard sexual health screening covers chlamydia, gonorrhea, HIV, syphilis, and sometimes hepatitis, which is what the evidence supports.
When testing is warranted, typically in cases of persistent urethritis after other infections have been ruled out, or in the context of pregnancy complications, PCR-based tests are more reliable than traditional culture. In one comparison study, culture identified only 5 confirmed positive samples out of 50 specimens, while PCR detected Ureaplasma in 12, making it roughly twice as sensitive and significantly faster.
Treatment When It’s Needed
For the minority of cases where Ureaplasma is genuinely causing symptoms and other causes have been excluded, antibiotics from the tetracycline family are the most reliable option. Globally, resistance to tetracyclines in Ureaplasma species sits below 10%, making them a dependable first-line choice. Resistance to fluoroquinolones is far more common at around 66%, and roughly 19% of Ureaplasma strains resist macrolide antibiotics.
Treatment courses are generally short. Most people who need treatment receive a week-long course, and symptoms typically resolve within that time. Retreatment is sometimes necessary, particularly when antibiotic resistance is involved, but the high effectiveness of tetracyclines means most cases clear on the first attempt.
What a Positive Result Actually Means
If you’ve tested positive for Ureaplasma through a private lab and you have no symptoms, the most likely explanation is that you’re carrying a normal genital organism that isn’t causing you harm. This is not the same as having an STI, and it doesn’t mean you need treatment or that you’ve done something wrong.
If you do have symptoms like burning urination, unusual discharge, or pelvic pain, the right next step is getting tested for the standard STIs that are known to cause those symptoms. Ureaplasma only becomes a serious suspect after chlamydia, gonorrhea, and other common culprits have been ruled out and symptoms persist. In the context of recurrent pregnancy loss or preterm labor, testing and treating Ureaplasma is better supported by evidence and more likely to be recommended by a specialist.